The Week Ahead: HCV Takes Center Stage; ASN, ACR, and AHA in the Wings

by MedPage Today • 2014/11/09 • 0 Comments

(MedPage Today) -- HCV treatment will again make headlines at the AASLD meeting and MedPage Today drills down with special features on renal cell carcinoma and multiple myeloma the week of Nov. 10.

← Positive patient outcomes reported at 1 year with retina implant

Quarterly net revenue increases to $2.4 million for Alimera →

Post navigation